68 related articles for article (PubMed ID: 28097409)
1. Genetic and Epigenetic Intra-tumour Heterogeneity in Colorectal Cancer.
Jones HG; Jenkins G; Williams N; Griffiths P; Chambers P; Beynon J; Harris D
World J Surg; 2017 May; 41(5):1375-1383. PubMed ID: 28097409
[TBL] [Abstract][Full Text] [Related]
2. Tumor Heterogeneity in Colorectal Cancer: What Do We Know So Far?
Sagaert X; Vanstapel A; Verbeek S
Pathobiology; 2018; 85(1-2):72-84. PubMed ID: 29414818
[TBL] [Abstract][Full Text] [Related]
3. Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
Joung JG; Oh BY; Hong HK; Al-Khalidi H; Al-Alem F; Lee HO; Bae JS; Kim J; Cha HU; Alotaibi M; Cho YB; Hassanain M; Park WY; Lee WY
Clin Cancer Res; 2017 Dec; 23(23):7209-7216. PubMed ID: 28939741
[No Abstract] [Full Text] [Related]
4. The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses.
Xu C; Liu Y; Zhang Y; Gao L
Front Genet; 2022; 13():928105. PubMed ID: 36313449
[No Abstract] [Full Text] [Related]
5. Identification of genes with high heterogeneity of expression as a predictor of different prognosis and therapeutic responses in colorectal cancer: a challenge and a strategy.
Salehitabar E; Mahdevar M; Valipour Motlagh A; Forootan FS; Feizbakhshan S; Zohrabi D; Peymani M
Cancer Cell Int; 2022 Sep; 22(1):276. PubMed ID: 36064367
[TBL] [Abstract][Full Text] [Related]
6. Application of mTORC1 Inhibitors for Tissue-Agnostic Management of Standard-Therapy-Refractory Solid Tumors.
Taghizadeh H; Maj-Hes A; Prager GW; Müllauer L; Mader RM
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454843
[TBL] [Abstract][Full Text] [Related]
7. Prediction of lymph node metastasis in early colorectal cancer based on histologic images by artificial intelligence.
Takamatsu M; Yamamoto N; Kawachi H; Nakano K; Saito S; Fukunaga Y; Takeuchi K
Sci Rep; 2022 Feb; 12(1):2963. PubMed ID: 35194184
[TBL] [Abstract][Full Text] [Related]
8. Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
Hu LF; Lan HR; Huang D; Li XM; Jin KT
Front Oncol; 2021; 11():769305. PubMed ID: 34888246
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Impact of Intratumoral Heterogeneity of Esophageal Cancer on Pathological Diagnosis and P16 Methylation and the Representativity of Endoscopic Biopsy.
Qin Y; Zhou J; Fan Z; Gu J; Li X; Lin D; Deng D; Wei W
Front Oncol; 2021; 11():683876. PubMed ID: 34485122
[TBL] [Abstract][Full Text] [Related]
10. Improving the overall survival prognosis prediction accuracy: A 9-gene signature in CRC patients.
Zheng W; Lu Y; Feng X; Yang C; Qiu L; Deng H; Xue Q; Sun K
Cancer Med; 2021 Sep; 10(17):5998-6009. PubMed ID: 34346563
[TBL] [Abstract][Full Text] [Related]
11. Mapping the colorectal tumor microbiota.
Murphy CL; Barrett M; Pellanda P; Killeen S; McCourt M; Andrews E; O' Riordain M; Shanahan F; O'Toole P
Gut Microbes; 2021; 13(1):1-10. PubMed ID: 34030582
[TBL] [Abstract][Full Text] [Related]
12. Precision Medicine for the Management of Therapy Refractory Colorectal Cancer.
Taghizadeh H; Mader RM; Müllauer L; Erhart F; Kautzky-Willer A; Prager GW
J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33322358
[TBL] [Abstract][Full Text] [Related]
13. Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability.
Flatin BTB; Vedeld HM; Pinto R; Langerud J; Lind GE; Lothe RA; Sveen A; Jeanmougin M
Int J Cancer; 2021 Apr; 148(7):1652-1657. PubMed ID: 33284993
[TBL] [Abstract][Full Text] [Related]
14. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
15. Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma.
Ma R; Zhao Y; He M; Zhao H; Zhang Y; Zhou S; Gao M; Di D; Wang J; Ding J; Wei M
Cancer Cell Int; 2019; 19():360. PubMed ID: 31892859
[TBL] [Abstract][Full Text] [Related]
16. Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
Advani SM; Advani PS; Brown DW; DeSantis SM; Korphaisarn K; VonVille HM; Bressler J; Lopez DS; Davis JS; Daniel CR; Sarshekeh AM; Braithwaite D; Swartz MD; Kopetz S
BMC Cancer; 2019 Oct; 19(1):964. PubMed ID: 31623592
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine?
Molinari C; Marisi G; Passardi A; Matteucci L; De Maio G; Ulivi P
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477151
[TBL] [Abstract][Full Text] [Related]
18. Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer Patients.
Fouad MA; Salem SE; Hussein MM; Zekri ARN; Hafez HF; El Desouky ED; Shouman SA
Front Pharmacol; 2018; 9():1173. PubMed ID: 30405408
[No Abstract] [Full Text] [Related]
19. The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.
Zou SM; Li WH; Wang WM; Li WB; Shi SS; Ying JM; Lyu N
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2149-2159. PubMed ID: 30171333
[TBL] [Abstract][Full Text] [Related]
20. Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells.
Vijayaraghavalu S; Labhasetwar V
Drug Deliv Transl Res; 2018 Oct; 8(5):1289-1299. PubMed ID: 29947019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
